Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

IBM Launches New Solution for Emerging Field of Personalized Medicine

26.07.2004


IBM Clinical Genomics Solution Provides the Technology Infrastructure to Help Accelerate Information-Based Medicine

IBM today announced a new information technology (IT) solution designed to assist medical researchers and physicians bridge the gap between clinical research and patient care. By offering services and technology to identify the molecular mechanisms of disease and ultimately develop more personalized medicine, the IBM Healthcare and Life Sciences Clinical Genomics Solution is designed to further information-based medicine, a new way in which healthcare is developed and delivered.

The IBM Healthcare and Life Sciences Clinical Genomics Solution enables research institutions and biopharmaceutical companies across the world to integrate, store, analyze and better understand genotypic and phenotypic data for medical research and patient care. Critical components of the solution include business consultant services, business strategy and process re-engineering, and:



The Medical Information: interfaces with hospital and research systems to capture and de-identify information from each patient or research encounter, helping to ensure patient security and privacy

The Medical Information Broker: pulls data from multiple healthcare institutions and diagnostic laboratories to be stored in the Medical Information Repository

The Medical Information Repository: centralizes data for integrated clinical and high-throughput research, enabling an organization to fully leverage its information assets

IBM DB2 ® Information Integrator: Helps increase researchers’ productivity by providing seamless access to additional data in external databases such as Medline, dbSNP and GenBank

IBM Business Partner Platforms: complete solution through powerful technologies offered by IBM Business Partners

"Globally, healthcare is undergoing a profound transformation toward targeted therapeutics and treatment regimens. Working with our Business Partners, IBM is deeply committed to shedding light on the critical role information technology will play in personalized medicine," said Mike Svinte, vice president, information-based medicine, IBM. "We’ve built our clinical genomics services practice to aid this transformation by enhancing drug discovery and medical practices with knowledge generated from diverse clinical and biomedical data. Our new solution will help clients achieve this vision of information-based medicine by accelerating our understanding of disease."

The IBM Healthcare and Life Sciences Clinical Genomics Solution reflects IBM’s deep commitment to advancing healthcare and life sciences and leverages cutting-edge work by IBM Research as well as companies such as the Mayo Clinic and the H. Lee Moffitt Cancer Center and Research Institute.

Information-based medicine is the use of IT to cross-reference clinical information -- such as patient records, family histories and lab tests -- with knowledge about the human genome. By understanding illnesses on the molecular level, including gene variations linked to disease or drug response, doctors may be able to make more precise diagnoses and tailor treatment decisions. Similarly, drug makers can work to develop more targeted treatment therapies and identify potential clinical trail participants more effectively.

The IBM Healthcare and Life Sciences Clinical Genomics Solution can help facilitate companies’ compliance with rigorous patient privacy and security standards, such as HIPAA. Every implementation leverages IBM’s security framework, which is based on the Tivoli® suite of products. Tivoli applications help institutions define consistent security policies -- based on both internal requirements and industry standards -- and monitor compliance. Other products used in the clinical genomics solution include the IBM ® pSeries®, IBM DB2 Universal Database® and IBM WebSphere® Portal Server.

Jorge Alberni | IBM Corporation
Further information:
http://www.ibm.com

More articles from Information Technology:

nachricht Robots as Tools and Partners in Rehabilitation
17.08.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht Low bandwidth? Use more colors at once
17.08.2018 | Purdue University

All articles from Information Technology >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>